Re: Rana R. McKay, Xun Lin, Julia J. Perkins, Daniel Y.C. Heng, Ronit Simantov, Toni K. Choueiri. Prognostic significance of bone metastases and bisphosphonate therapy in patients with renal cell carcinoma. Eur Urol 2014;66:502-9.
University Hospitals Leuven, Leuven, Belgium. Electronic address: benoit.beuselinck@uzleuven.be.
Benoit
B
Beuselinck
University Hospitals Leuven, Leuven, Belgium.
Pascal
P
Wolter
Auckland City Hospital, Auckland, New Zealand.
Reuben
R
Broom
D050071:Bone Density Conservation Agents / Q000627:therapeutic use*; D001859:Bone Neoplasms / Q000188:drug therapy*; D002292:Carcinoma, Renal Cell / Q000188:drug therapy*; D004164:Diphosphonates / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D007093:Imidazoles / Q000627:therapeutic use*; D007680:Kidney Neoplasms / Q000188:drug therapy*; D008297:Male
D050071:Bone Density Conservation Agents; D004164:Diphosphonates; D007093:Imidazoles